Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03451123 · ClinicalTrials.gov registry record · Early Phase 1
FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors
A Early Phase 1 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 1
- Enrollment target
NCT03451123 is a Early Phase 1 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 1 participants.
The verdict
NCT03451123, a Early Phase 1 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The primary objectives of this study are: 1. Determine the percentage of patients whose surgical plan would change with FET-PET/MRI compared to MRI alone. 2. Determine the percentage of patients who have residual tumor after surgery detected with FET-PET/MRI. A secondary objective of this study is: 1\) Perform preliminary correlations between the pre- and post-surgical metabolic tumor volumes measured with FET-PET/MRI to progression free survival.
Interventions
- DRUG FET PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-04-23 |
| Est. Completion | 2023-08-29 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03451123
The ClinicalTrials.gov registry entry for NCT03451123 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FET PET/MRI is the first listed.
NCT03451123 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03451123 about?
NCT03451123 is a clinical study titled "FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors". The primary objectives of this study are: 1. Determine the percentage of patients whose surgical plan would change with FET-PET/MRI compared to MRI alone. 2. Determine the percentage of patients who have residual tumor after surgery detected with FET-PET/MRI. A secondary objective of this study is...
What is the current status of trial NCT03451123?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2018-04-23. Estimated completion is 2023-08-29.
What interventions are being tested in trial NCT03451123?
The interventions under investigation include: FET PET/MRI (DRUG).
Who is sponsoring clinical trial NCT03451123?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.